Response Genetics Enters Next Generation Sequencing Market With Proprietary Panel for Lung Cancer Developed by the Knight Cancer Institute at Oregon Health & Science University
April 21, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, April 21, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Contracts With Six New Provider Networks
April 03, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, April 3, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
March 20, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, March 20, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on March 20, 2014
March 12, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, March 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Offer Expanded KRAS Mutation Test to Improve Treatment Decisions for Colorectal Cancer Patients
March 10, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, March 10, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer today announced the...
Response Genetics Receives Third GSK Milestone Payment
January 27, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Contracts With Two Additional Blue Cross Blue Shield Plans
December 18, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Pricing of Underwritten Public Offering
December 13, 2013 09:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine a...
Response Genetics, Inc. Announces Proposed Underwritten Public Offering
December 12, 2013 16:33 ET
|
Response Genetics, Inc.
LOS ANGELES, Dec. 12, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine a...
Response Genetics, Inc. Announces Four New Contracts With National PPO Networks
November 13, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...